Established since 2007, nanoPET Pharma holds a firm standing in both preclinical (Viscover) and clinical (Xiralite) diagnostic imaging.

We act as a technology and service provider to the biopharmaceutical industry, focusing on R&D, production, and marketing of innovative drug substances for preclinical imaging. Our Viscover imaging agent portfolio boasts cutting-edge products for use in MRI, CT, ultrasound, and optical imaging, and is accessible to the imaging community worldwide.

Moreover, nanoPET Pharma is active in the clinical diagnostic imaging world through its subsidiary company Xiralite. Here, we develop, manufacture and globally supply highly invaluable medical devices to improve the care of patients with rheumatic diseases.